Rx Medicare

ImmuneRegen BioSciences Inc.?, a wholly owned subsidiary of IR Biosciences Holdings Inc. (OTCBB: IRBS), today announced additional positive results from a recent study that evaluated its lead anti-influenza drug, Homspera?, in ferrets…

Read More…

Related Posts

• SciClone And Sigma-Tau Announce Additional Positive Results In Clinical Study Examining ZADAXIN’s Ability To Enhance Response To H1N1 Vaccine
• SciClone And Sigma-Tau Announce Positive Preliminary Results In Clinical Study Examining ZADAXIN’S Ability To Enhance Response To H1N1 Vaccine
• SinoFresh Nasal Spray Achieves Positive Results Against H1N1 (Swine Flu) Virus In Initial Pilot Animal Study
• AcelRx Announces Positive Phase 2 Results From A Study Of ARX-01 Sufentanil NanoTabs In Treating Post-Operative Pain
• Viroblock SA Reports Positive Results Of Preclinical Studies In Antiviral Nasal Spray For Influenza
• King Pharmaceuticals Announces Positive Results From A 12-Month Open-Label Safety And Efficacy Study Of EMBEDA? Extended Release Capsules
• Baxter Presents Clinical Efficacy Results From Phase III Study Of Seasonal Flu Vaccine
• Alkermes Announces Positive Results For Phase 1 Study Of New Drug Candidate For Treatment Of Opioid-Induced Constipation
• Phosphagenics Announces Positive Results From Phase 1B Study Of Transdermal Oxycodone Patch
• Implications Of Influenza Pandemics On Blood Supplies Highlighted By Study
• Vaccination, Antivirals And Social Distancing May Blunt Impact Of H1N1 Influenza, Finds Epidemiological Modelling Study
• NanoViricides Presents FluCide™ Animal Study Data At Influenza Congress – Now Improved Substantially And Vastly Superior To Current Treatment
• FDA Approves Additional Vaccine For 2009 H1N1 Influenza Virus
• AcelRx Announces Positive Results From A Phase 2 Study Of ARX-03, A Sufentanil/Triazolam NanoTab For Procedural Sedation, Anxiolysis & Analgesia
• Transdel Pharmaceuticals Announces Positive Phase 3 Study Results For Lead Topical Pain Drug Ketotransdel(R)

Tags: additional, biosciencesr, efficacy, highly, homsperar, immuneregen, influenza, pathogenic, positive, results, study, treating

This entry was posted on Wednesday, January 6th, 2010 at 6:01 pm and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.